Live feed
Filing
SC 13G
SC 13G0001019056-20-000505·Rosalind Advisors, Inc.
Schedule 13G ownership disclosure
VISTAGEN THERAPEUTICS INC
Security class unavailable · CUSIP: 92840H202
Event date: 2020-09-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,000,000
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-20-000505
- Form type
- SC 13G
- Filer
- Rosalind Advisors, Inc.
- CIK
- CIK 1622627
- Filed
- Sep 18, 2020
- Reporting period
- Sep 15, 2020
- Description
- Schedule 13G beneficial ownership